One advantage of mRNA technology is that it can be quickly adapted to produce vaccines effective against new viral mutations. — AFP
The Pfizer/BioNTech vaccine appears to be effective against the new, more infectious SARS-CoV-2 virus variant that was first detected in the United Kingdom and has since been found in dozens of countries, according to two preliminary studies released on Jan 20 (2021).
The strain, known as B.1.1.7, has caused alarm among experts because of its increased ability to spread and supercharge virus outbreaks.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
